David Tanen
Gründer bei KRONOS BIO, INC.
Vermögen: 895 507 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von David Tanen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 | |
| Public Company | Pharmaceuticals: Major | 20 | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts.
15
| Private Company | Investment Managers | 15 |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York.
13
| Private Company | Investment Managers | 13 |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY.
11
| Subsidiary | Biotechnology | 11 |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Nile Therapeutics, Inc. /Old/
8
| Extinct | Pharmaceuticals: Major | 8 |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY.
8
| Private Company | Biotechnology | 8 |
| Public Company | Pharmaceuticals: Major | 7 | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
5
| Private Company | Investment Managers | 5 |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The private company is based in New York, NY.
3
| Subsidiary | Investment Banks/Brokers | 3 |
Two Rivers Consulting Corp.
1
| Private Company | 1 | |
Two River Group Management LLC
1
| Private Company | 1 | |
Two River Consulting LLC
 Two River Consulting LLC Miscellaneous Commercial ServicesCommercial Services Two River Consulting LLC provides management consulting services. The private company is based in Franklin Lakes, NJ. The company was founded by David M. Tanen.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Tanen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| KITE PHARMA INC | Biotechnology | Founder Chief Executive Officer Private Equity Investor Director/Board Member Director/Board Member Investor Relations Contact Comptroller/Controller/Auditor Director/Board Member Founder Private Equity Investor | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Director/Board Member General Counsel Director/Board Member Founder | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Director/Board Member Chairman Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Director/Board Member Consultant / Advisor Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder Founder Director/Board Member Founder | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| New York University | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor General Counsel | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman Director/Board Member | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Orion Biomedical Fund LP | Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | ||
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman Director of Finance/CFO Director/Board Member | |
| TFF PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Consultant / Advisor Corporate Secretary Chief Tech/Sci/R&D Officer | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The private company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer |
Statistik
International
| Vereinigte Staaten | 49 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 15 |
| Finance | 11 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 567 |
| Corporate Officer/Principal | 235 |
| Independent Dir/Board Member | 122 |
| Chairman | 109 |
| Founder | 100 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Tomer Kariv | 46 |
| Franz Humer | 45 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Otello Stampacchia | 37 |
| Martin Murphy | 33 |
| Helen Kim | 33 |
| Peter Morgan Kash | 32 |
| Randy Thurman | 28 |
| David Guyer | 27 |
| Michael Weiser | 26 |
| Neil William Flanzraich | 25 |
| Barrett Katz | 23 |
| Jay Moorin | 21 |
- Börse
- Insiders
- David Tanen
- Unternehmensverbindungen
